FZABX
Price
$29.93
Change
+$0.23 (+0.77%)
Updated
Sep 4 closing price
Net Assets
1.55B
RERAX
Price
$57.98
Change
+$0.30 (+0.52%)
Updated
Sep 5 closing price
Net Assets
132.86B
Interact to see
Advertisement

FZABX vs RERAX

Header iconFZABX vs RERAX Comparison
Open Charts FZABX vs RERAXBanner chart's image
Fidelity Advisor Diversified Intl Z
Price$29.93
Change+$0.23 (+0.77%)
VolumeN/A
Net Assets1.55B
American Funds EUPAC R1
Price$57.98
Change+$0.30 (+0.52%)
VolumeN/A
Net Assets132.86B
FZABX vs RERAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FZABX vs. RERAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZABX is a Hold and RERAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 133B vs. FZABX (1.55B). FZABX pays higher dividends than RERAX: FZABX (1.64) vs RERAX (0.23). FZABX was incepted earlier than RERAX: FZABX (12 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than FZABX (0.73). RERAX is a more actively managed with annual turnover of: 35.00 vs. FZABX (33.00). FZABX has a lower initial minimum investment than RERAX: FZABX (0) vs RERAX (250). FZABX annual gain was more profitable for investors over the last year : 9.16 vs. RERAX (7.44). FZABX return over 5 years is better than : 20.60 vs. RERAX (7.30).
FZABXRERAXFZABX / RERAX
Total Expense Ratio0.731.5746%
Annual Report Gross Expense Ratio0.731.5746%
Fund Existence12 years23 years-
Gain YTD18.25414.971122%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B133B1%
Annual Yield % from dividends1.640.23717%
Returns for 1 year9.167.44123%
Returns for 3 years44.1232.30137%
Returns for 5 years20.607.30282%
Returns for 10 years59.2633.08179%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCORF7.42N/A
N/A
Canaccord Genuity Group, Inc.
KSBI56.00N/A
N/A
K S Bancorp, Inc.
BUHPF4.85N/A
N/A
Bumrungrad Hospital Public Co., Ltd.
SDZXF62.16N/A
N/A
Sandoz Group AG
FDXTD0.51-0.03
-6.29%
Fendx Technologies Inc.